| Index | Ligand Name | Structure | PDB code | ligand desolvation |
| 1 | 94f | Co-crystal Structure of KRAS (G12C) covalently bound with Quinazoline based inhibitor JBI739 | 5yy1 | 97.02 |
| 2 | 91s | Crystal Structure of small molecule ARS-1620 covalently bound to K-Ras G12C | 5v9u | 96.71 |
| 3 | 5ut | Crystal Structure of small molecule ARS-853 covalently bound to K-Ras G12C | 5f2e | 96.45 |
| 4 | 8yd | Crystal structure of small molecule acrylamide 1 covalently bound to K-Ras G12C | 5v6s | 94.82 |
| 5 | o5v | Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor. | 6p8x | 93.74 |
| 6 | k9m | Tetrahydropyridopyrimidines as Covalent Inhibitors of KRAS-G12C | 6n2j | 93.22 |
| 7 | c8g | Crystal Structure of small molecule ARS-107 covalently bound to K-Ras G12C | 6b0v | 92.22 |
| 8 | 8zg | Crystal Structure of small molecule ARS-917 covalently bound to K-Ras G12C | 6b0y | 92.17 |
| 9 | 20h | Crystal Structure of small molecule disulfide 4 covalently bound to K-Ras G12C | 4lv6 | 87.67 |
| 10 | 20g | Crystal Structure of small molecule disulfide 6 bound to K-Ras G12C | 4luc | 86.92 |
| 11 | k9j | Tetrahydropyridopyrimidines as Covalent Inhibitors of KRAS-G12C | 6n2k | 86.36 |
| 12 | 94c | Co-crystal Structure of KRAS (G12C) covalently bound with Quinazoline based inhibitor JBI484 | 5yxz | 86.26 |
| 13 | 8ya | Crystal structure of small molecule aziridine 3 covalently bound to K-Ras G12C | 5v6v | 85.55 |
| 14 | 91g | KRAS G12C inhibitor | 5v9o | 84.24 |
| 15 | o67 | Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor. | 6p8w | 83.14 |
| 16 | 21f | Crystal Structure of small molecule vinylsulfonamide 9 covalently bound to K-Ras G12C, alternative space group | 4lyj | 81.82 |
| 17 | 21f | Crystal Structure of small molecule vinylsulfonamide 9 covalently bound to K-Ras G12C | 4lyh | 81.23 |
| 18 | 21c | Crystal Structure of small molecule vinylsulfonamide 8 covalently bound to K-Ras G12C | 4lyf | 78.42 |
| 19 | 8zg | KRAS G12C in bound to quinazoline based switch II pocket (SWIIP) binder | 5v71 | 76.23 |
| 20 | o5s | Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor | 6p8z | 74.59 |
| 21 | o5y | Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor. | 6p8y | 72.62 |
| 22 | 91d | KRAS G12C in bound to quinazoline based switch II pocket (SWIIP) binder | 5v9l | 64.78 |